Dermatology Drugs Market to Reach USD 63.99 Billion with a CAGR of 12.9%by 2027; Increasing Prevalence of Acne and Vitiligo to Spur Business Opportunities, states Fortune Business Insights™

Key Prominent Players Covered in the Dermatology Drugs Market Research Report Are Allergan, Botanix Pharmaceuticals, Pfizer Inc., Galderma S.A, Bausch Health Companies Inc., Novartis, GlaxoSmithKline Plc., Valeant Pharmaceuticals International Inc., Johnson & Johnson and other key market players.

Pune INDIA


Pune, India, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The global dermatology drugs market size is expected to USD 63.99 billion by 2027, exhibiting a CAGR of 12.9% during the forecast period. The increasing prevalence of numerous skin diseases and disorders among the population is expected to spur opportunities for the market, states Fortune Business Insights, in a report, titled “Dermatology Drugs Market Size, Share & COVID-19 Impact Analysis, By Application (Acne, Psoriasis, Atopic Dermatitis, and Others), By Route of Administration (Oral, Parenteral, and Topical) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The market size stood at USD 36.82 billion in 2019.

KEY INDUSTRY DEVELOPMENTS:

  • June 2020 – Alembic Pharmaceuticals received U.S FDA approval for generic Adapalene Gel useful against the treatment of acne vulgaris.
  • October 2019 – Almirall, S.A launched a ‘Digital Garden’ initiative with an aim to boost start-ups to focus on dermatology digital health.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermatology-drugs-market-104432


Surging Patient Population to Back Growth

The growing number of patients suffering from acne, vitiligo, and dermatitis are expected to spur opportunities for market growth. According to the American Association of Dermatology in 2018, around 50 million people in the U.S had acne. The growing demand for effective products to cure skin infections and disorders coupled with high awareness among the young population will contribute positively to the growth of the market.

According to Australian research, more than 4% of the population are affected by acne vulgaris in long term. The growing inclination towards skin health and care among millennials can have an excellent impact on the market growth in the forthcoming years. The increasing R&D investments by major companies owing to heavy demand for therapeutically effectual and cost-effective drugs will encourage the healthy growth of the market in the foreseeable future.


Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/dermatology-drugs-market-104432


Diminished Demand for Dermatology Drugs to Impede Market amid COVID-19

The COVID-19 pandemic has critically impacted the global market because of the weakened demand for dermatology drugs. Pharmaceutical companies producing skin-related drugs experienced massive losses owing to the lockdown imposed by governments.

Thus, leading to disrupted supply and demand. Social distance regulations coupled with lower demand for mandatory prescribed dermatology medications will further restrict the growth of the market. According to the American Association of Dermatology, the dermatologists in the U.S reported an approximately 43% decline in patient consultations during the pandemic crisis. In addition, declining production and demand will simultaneously affect market sales during the coronavirus pandemic.


Quick Buy -  Dermatology Drugs Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104432


Presence of Prominent Companies to Boost Market in North America

The market size in North America stood at USD 18.08 billion in 2019 and is expected to grow rapidly during the forecast period. The growth in the region is attributed to the increasing prevalence of dermatology infections. The presence of major players coupled with the introduction of novel products will further aid expansion in the region. Europe is expected to grow excellently during the forecast period owing to the heavy R&D investments for the development of effective drugs.

The increasing sales of dermatology products are expected to enable speedy expansion of the market in the forthcoming years. Asia Pacific is expected to account for a high share during the forecast period owing to the growing awareness about the care & management of acne among the population. Latin America and Middle East & Africa are expected to experience a slow growth rate owing to the lower adoption of topical solutions coupled with a lack of awareness about medicines and therapies related to acne, dermatitis, and other skin conditions.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermatology-drugs-market-104432


The Report Lists the Key Companies in the Dermatology Drugs Market:

  • Allergan (Dublin, Ireland)
  • Botanix Pharmaceuticals (NorthBridge, Australia)
  • Pfizer Inc. (New York, U.S)
  • Galderma S.A (Lausanne, Switzerland)
  • Bausch Health Companies Inc. (Bridgewater, U.S)
  • Novartis (Switzerland, Europe)
  • GlaxoSmithKline Plc. (London, U.K)
  • Valeant Pharmaceuticals International Inc. (New Jersey, U.S)
  • Johnson & Johnson (New Jersey, U.S)
  • Other Players


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/dermatology-drugs-market-104432


Table of Contents:

  • Introduction
    • Market Scope
    • Market Segmentation
    • Market Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Key Dermatologic Conditions –Key Regions/Country
    • New Product Launch
    • Pipeline Analysis
    • Impact of COVID-19 on the Dermatology Drugs Market
    • Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • Global Dermatology Drugs Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Application
      • Acne
      • Psoriasis
      • Atopic Dermatitis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Parenteral
      • Topical
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Geography
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa


TOC Continued….!


Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/dermatology-drugs-market-104432


SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.


Have a Look at Related Reports:

Healthcare Analytics Market Share & Industry Analysis, By Product (Descriptive, Predic-tive, and Prescriptive), By Application (Financial Analytics, Population Health Analytics, Clinical Analytics, and Operations and Administrative Analytics), By End User (Payers, Providers, and Others) and Regional Forecast, 2019-2026

Non-Hodgkin Lymphoma Treatment Market Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (B-cell Lymphoma, and T-cell Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2019-2026

Active Pharmaceutical Ingredient (API) Market Share & Industry Analysis, By Type (Generic API, and Branded API), By Synthesis (Biological API, and Synthetic API), and Regional Forecast, 2019-2026

Contract Manufacturing Organization (CMO) Market Share & Industry Analysis, By Type (API Manufacturing, Finished Dosage Form Manufacturing (Solid Dosage Forms, Injectables, and Others), and Packaging), and Regional Forecast, 2019-2026

Electronic Health Records (EHR) Market Share & Industry Analysis, By Product (Web-based, On-premise), By Type (Stand Alone, Integrated) By End User (Physician’s Office, Hospitals, Others) and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs


Press Release: https://www.fortunebusinessinsights.com/press-release/global-dermatology-drugs-market-10309